I went last year to hear Dr. Shah speak, enjoyed everything about the conference. Have signed up again!
Emerging Therapies and Survivorship for Blood Cancer Patients
An update from the American Society of Hematology (ASH)® Annual Meeting
The Leukemia & Lymphoma Society (LLS) is pleased to bring the latest advances in blood cancer research, clinical trials and disease management to Northern California patients and their caregivers. Please mark your calendars for this special patient conference. Emerging Therapies is a free educational program, but space is limited and registration is required.
Saturday, February 9, 2013
9:00 a.m. - 12:30 p.m.
Hyatt Regency San Francisco (New Location)
5 Embarcadero Center, San Francisco, CA 94111
How to register
To reserve your space, please complete the online registration form at:bit.ly/emergingtherapies
Program Agenda
9:00 a.m. Arrival and Breakfast Served
9:30 a.m. LLS Mission Programs Update
Why Public Policy Matters for Blood Cancer Patients
9:45 a.m. Perspectives on Survivorship: A Panel Discussion
10:30 a.m. Concurrent Breakout Sessions
Chronic Lymphoid Leukemia: Steven Coutré, M.D.
Associate Professor of Medicine, Division of Hematology, Stanford University School of Medicine
Chronic Myeloid Leukemia: Neil Shah, M.D., Ph.D.
Assistant Professor, Division of Hematology/Oncology, UCSF School of Medicine
Multiple Myeloma: Jeffrey Wolf, M.D.
Clinical Professor of Medicine and Director of the Myeloma Institute, Helen Diller Family Comprehensive Cancer Center, UCSF
Myelodysplastic Syndromes: Peter Greenberg, M.D.
Professor Emeritus, Medicine - Hematology, Stanford University School of Medicine
Non-Hodgkin Lymphoma (High Grade/Aggressive): Weiyun Ai, M.D., Ph.D.
Clinical Assistant Professor of Medicine; Division of Hematology/Oncology, UCSF
Non-Hodgkin Lymphoma (Low Grade/Indolent): C. Babis Andreadis, M.D., MSCE
Assistant Clinical Professor of Medicine, Adult Bone Marrow Transplantation Program, Helen Diller Family Comprehensive Cancer Center, UCSF
The 2013 Northern California Emerging Therapies and Survivorship conference is made possible by the generosity of our partners and sponsors.
2013 Partners: Association of Northern California Oncologists, Marin Specialty Care, Redwood Regional Oncology Center, Stanford Cancer Center, and University of California, San Francisco Helen Diller Family Comprehensive Cancer Center
2013 Sponsors: Millennium, Genentech, Onyx Pharmaceuticals, Celgene and Teva
